Product image of Granisetron Stada (Granisetron) supplied by GNH India

Granisetron Stada

Active Ingredient:
Granisetron
Origin:
EU

Granisetron Stada (Granisetron)

Granisetron Stada is an oral medication that contains the active ingredient granisetron, a selective 5‑HT3 receptor antagonist used as an antiemetic. It is marketed in the European Union and is available only by prescription. The product works by blocking serotonin receptors in the central nervous system and gastrointestinal tract, helping to prevent nausea and vomiting associated with chemotherapy or surgery or other medically induced triggers.

Manufacturer / TM Owner

Stadapharm Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Granisetron Stada is indicated for the prevention of nausea and vomiting in specific clinical situations, particularly when serotonin pathways are involved.

  • Prevention of chemotherapy‑induced nausea and vomiting (CINV) in adult patients.
  • Prevention of postoperative nausea and vomiting (PONV) following surgical procedures.
  • Use as part of a multimodal antiemetic regimen when serotonin‑mediated emesis is anticipated.
  • May be considered for patients receiving highly emetogenic chemotherapy agents.
  • Adjunctive therapy for radiation‑induced nausea when other antiemetics are insufficient.

Side Effects

The safety profile of Granisetron Stada reflects its pharmacologic class; most patients experience mild, transient effects, while serious reactions are uncommon.

Common

  • Headache.
  • Constipation.
  • Dizziness.
  • Fatigue.
  • Mild diarrhea.

Serious

  • Allergic reactions such as rash, itching, or swelling.
  • QT interval prolongation leading to cardiac arrhythmia.
  • Severe hypotension.
  • Anaphylaxis.

Precautions & Warnings

Before prescribing Granisetron Stada, clinicians should evaluate several precautionary factors to ensure safe use.

  • Assess cardiac history, especially for prolonged QT interval.
  • Use cautiously in patients with hepatic impairment; dose adjustment may be required.
  • Evaluate renal function, as accumulation can occur in severe renal failure.
  • Consider pregnancy and breastfeeding status; safety data are limited.
  • Review concomitant medications that may affect serotonin levels or cardiac conduction.
  • Monitor for signs of hypersensitivity during initial therapy.

Avoid Interactions

Granisetron Stada can interact with other drugs that influence serotonin pathways or cardiac electrophysiology.

Avoid

  • Combined use with other 5‑HT3 antagonists or high‑dose serotonin antagonists.
  • Co‑administration with drugs known to prolong QT interval (e.g., certain antiarrhythmics, antipsychotics).

Use with caution

  • CYP3A4 inhibitors (e.g., ketoconazole, erythromycin) may increase granisetron levels.
  • CYP3A4 inducers (e.g., rifampin, carbamazepine) may reduce effectiveness.
  • Concurrent use of serotonergic agents (e.g., SSRIs, tramadol) may increase risk of serotonin syndrome.
  • Anticholinergic medications may exacerbate constipation.
  • Drugs that affect cardiac conduction should be reviewed before combination.

Frequently Asked Questions

Granisetron Stada is a prescription oral medication that contains granisetron, a selective 5‑HT3 receptor antagonist. It blocks serotonin receptors in the central nervous system and gastrointestinal tract, reducing the stimulus for nausea and vomiting.

It is typically used with highly or moderately emetogenic chemotherapy regimens, such as those that include cisplatin, cyclophosphamide, or anthracycline‑based protocols.

Granisetron Stada is taken by mouth, usually as a single dose before the start of chemotherapy or surgery. Specific dosing intervals depend on the clinical protocol and should be determined by a healthcare professional.

The safety and efficacy of Granisetron Stada in children have not been fully established, and its use in pediatric populations should be guided by a physician familiar with pediatric dosing guidelines.

Common side effects include headache, constipation, dizziness, fatigue, and mild diarrhea. These effects are generally transient and resolve without specific treatment.

Serious reactions, although rare, can include allergic responses (rash, itching, swelling), QT interval prolongation, severe hypotension, and anaphylaxis. Immediate medical attention is required if these occur.

Patients with known cardiac arrhythmias or a prolonged QT interval should be evaluated carefully. Monitoring of cardiac function and consideration of alternative antiemetics may be appropriate.

Avoid combining with other 5‑HT3 antagonists or drugs that prolong the QT interval. Use caution with CYP3A4 inhibitors or inducers, serotonergic agents, anticholinergics, and medications affecting cardiac conduction.

Safety data for use during pregnancy or lactation are limited. The medication should only be used if the potential benefit justifies the potential risk, and decisions should be made by a healthcare provider.

Granisetron Stada has a similar mechanism of action to other 5‑HT3 antagonists such as ondansetron and palonosetron. Comparative effectiveness may vary based on dosing, patient characteristics, and specific surgical contexts.

Granisetron Stada can be administered with or without food; however, patients should follow the specific instructions provided by their prescribing clinician.

Routine monitoring may include assessment for common side effects, evaluation of cardiac rhythm in patients at risk for QT prolongation, and observation for any signs of allergic reaction.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Granisetron

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT